Brentuximab Vedotin in CD30+ Lymphomas

Overview of attention for article published in Biologics in Therapy, March 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 1,222 followers.

Brentuximab Vedotin in CD30+ Lymphomas http://t.co/RDjN5AejgF

Reply Repost Favourite

REVIEW: Brentuximab Vedotin in CD30+ Lymphomas http://t.co/RDjN5AejgF

Reply Repost Favourite